Live Price
Live Volume
Biogen Market Segments
Overnight
*No Trades in Segment
After Hours
| Open | $251.65 |
|---|---|
| Close | $251.65 |
| Low | $251.65 |
| Low Change | 0.00 (0.00%) |
| High | $251.65 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 225.206K |
| Dollar Volume | $56.67M |
Regular Trading Hours
| Open | $255.25 |
|---|---|
| Close | $251.91 |
| Low | $250.65 |
| Low Change | -4.60 (-1.80%) |
| High | $255.42 |
| High Change | +0.17 (+0.07%) |
| Range | $4.77 |
| Volume | 586.327K |
| Dollar Volume | $147.70M |
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $253.40 |
|---|---|
| Close | $253.40 |
| Low | $253.40 |
| Low Change | 0.00 (0.00%) |
| High | $253.40 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 212.398K |
| Dollar Volume | $53.82M |
Regular Trading Hours Yesterday
| Open | $250.58 |
|---|---|
| Close | $253.60 |
| Low | $249.52 |
| Low Change | -1.06 (-0.42%) |
| High | $255.04 |
| High Change | +4.46 (+1.78%) |
| Range | $5.52 |
| Volume | 782.689K |
| Dollar Volume | $198.49M |
Premarket Yesterday
| Open | $250.00 |
|---|---|
| Close | $250.00 |
| Low | $250.00 |
| Low Change | 0.00 (0.00%) |
| High | $250.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 109 |
| Dollar Volume | $27.25K |
Biogen News
1 month agoinvesting.comBiogen shares may move 4.3% on Oct. 28 earnings release
1 month agoinvesting.comBiogen options flow points to short iron condor ahead of Oct. 16 expiry
1 month agoinvesting.comJPMorgan gets bullish on Biogen ahead of 2027 catalysts
1 month agobarrons.comBiogen Stock Could Keep Gaining. A J.P. Morgan Upgrade Is Just the Beginning.
1 month agoinvesting.comWhy is Biogen stock climbing today?
3 months agoinvesting.comWolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
4 months agoinvesting.comBiogen beats quarterly estimates as newer drugs fuel growth
4 months agoinvesting.comBiogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradox
4 months agoinvesting.comBiogen stock rises on positive Alzheimer’s drug trial data
4 months agobarrons.comBiogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem
Biogen Top Trades
Biogen's top trade so far today returned +0.50%, while the top short trade returned -1.80%.
Biogen Moving Averages
| 5 Day Moving Average (SMA5) | $253.12 |
|---|---|
| 10 Day Moving Average (SMA10) | $251.09 |
| 20 Day Moving Average (SMA20) | $249.27 |
| 50 Day Moving Average (SMA50) | $233.39 |
| 100 Day Moving Average (SMA100) | $221.28 |
| 200 Day Moving Average (SMA200) | $205.17 |
Biogen Statistics
| Average Volume (30 Days) | 1.25M |
|---|---|
| P/E Ratio (Current) | 107.83 |
| EPS (Current) | $2.35 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $2.07B |
| Cash Ratio | 0.33 |
| Current Ratio | 1.95 |
| Quick Ratio | 1.37 |
| Debt to Equity | 0.41 |
| Enterprise Value | $43.85B |
| EV to EBITDA | 22.71 |
| EV to Sales | 4.26 |
| Price to Book | 1.98 |
| Price to Cash Flow | 16.67 |
| Price to Free Cash Flow | 18.09 |
| Price to Sales | 3.64 |
| Return on Assets | 0.01% |
| Return on Equity | 0.02% |
Biogen Stock Splits
There have been no stock splits for Biogen (BIIB).
Biogen Dividends
There have been no dividends for Biogen (BIIB).